Illumina (ILMN) Sends Letter to Shareholders Over Roche (RHHBY) Bid; Says Price 'Inadequate'

Illumina, Inc. (Nasdaq: ILMN), has sent a second letter to its stockholders outlining Illumina’s unrivaled track record of superior operational performance and financial success. The letter urges stockholders to reject Roche’s (OTC: RHHBY) efforts to acquire Illumina at a grossly inadequate price, and reiterates the recommendation from Illumina’s Board that stockholders vote for the election of Illumina’s highly qualified director nominees at its 2012 Annual Meeting of Stockholders by completing the WHITE proxy card today.

For the full text, click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• J.M. Smucker names Jeff Varcoe as SVP of Science and Technical
• Zero Networks expands Palo Alto Networks integration with new features
• Cosmos Health signs Saudi distribution deal for supplement line